RE
REGN
Jun 30, 2024
Quarter ended Jun 30, 2024 · FY2024 Q2

Regeneron Pharmaceuticals, Inc. stock research

Regeneron Pharmaceuticals (REGN) Free Cash Flow — Quarter Ended Jun 30, 2024

Revenue increased from both the prior quarter and the same quarter last year, yet free cash flow declined sharply due to a lower operating cash flow conversion. The free cash flow margin weakened significantly compared with both periods.

Free cash flow takeaway

A quick read on the company's cash generation and what it means for investors.

Revenue increased from both the prior quarter and the same quarter last year, yet free cash flow declined sharply due to a lower operating cash flow conversion. The free cash flow margin weakened significantly compared with both periods.

  • Revenue rose while operating cash flow fell, resulting in a much lower free cash flow and a narrower free cash flow margin. Capital expenditure was higher than both the prior quarter and the year-ago quarter, further reducing free cash flow.
  • Compared with the immediately preceding quarter, revenue was higher but operating cash flow, free cash flow, and free cash flow margin were all lower. Versus the same quarter one year earlier, revenue was higher while operating cash flow, free cash flow, and free cash flow margin were lower.

FCF snapshot

Quarterly and TTM cash-flow metrics with the minimum valuation context.

TTM free cash flow

$3.3B

Trailing twelve-month free cash flow.

Quarter free cash flow

$173.5M

Free cash flow in the selected fiscal quarter.

Operating cash flow

$354.0M

Cash generated by operations before capital spending.

CapEx

$180.5M

Capital spending and related asset purchases.

FCF margin

4.9%

The share of revenue converted into free cash flow.

Cash flow trend

A short quarterly history shows whether FCF is scaling with revenue or only spiking for one period.

PeriodRevenueOperating CFCapExFCFFCF margin
2023-09-30$3.4B$1.1B$176.0M$938.3M27.9%
2023-12-31$3.4B$1.1B$251.4M$838.3M24.4%
2024-03-31$3.1B$1.5B$133.9M$1.4B43.8%
2024-06-30$3.5B$354.0M$180.5M$173.5M4.9%

Cash conversion quality

Checks that separate high-quality free cash flow from accounting noise or working-capital timing.

FCF / net income12.1%Shows whether accounting earnings convert into cash.
CapEx / revenue5.1%Lower capital intensity usually supports FCF margin.
Net cashn/aCash and equivalents minus total debt.

Recent events shaping cash flow

Near-term business events that help explain the free cash flow result.

Watch

Operating cash flow decline

Operating cash flow was lower than both the prior quarter and the year-ago quarter, despite higher revenue. This was the strongest observable driver of the weakened free cash flow and margin.

The lower operating cash flow directly reduced free cash flow and compressed the free cash flow margin.

What the cash flow says

How to interpret the company's free cash flow beyond the headline number.

Revenue rose while operating cash flow fell, resulting in a much lower free cash flow and a narrower free cash flow margin. Capital expenditure was higher than both the prior quarter and the year-ago quarter, further reducing free cash flow.

Compared with the immediately preceding quarter, revenue was higher but operating cash flow, free cash flow, and free cash flow margin were all lower. Versus the same quarter one year earlier, revenue was higher while operating cash flow, free cash flow, and free cash flow margin were lower.

Monitor the relationship between revenue growth and operating cash flow, as the current quarter shows a divergence with revenue higher but operating cash flow lower.